Pattern and Course of Neurodegeneration in Langerhans Cell Histiocytosis

Journal of Pediatrics

Volumn 153, Issue 1, 2008, Pages 127-132

  Wnorowski, Martha ^a   Prosch, Helmut ^b   Prayer, Daniela ^c   Janssen, Gisela ^d   Gadner, Helmut ^a   Grois, Nicole ^a  

^a ST ANNA CHILDREN S HOSPITAL   (Austria)

^b Otto Wagner Spital   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BASAL GANGLION; BRAIN DAMAGE; CEREBELLUM; CHILD; CONTROLLED STUDY; DENTATE NUCLEUS; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HISTIOCYTOSIS; HUMAN; INFANT; LANGERHANS CELL; MAJOR CLINICAL STUDY; MALE; NERVE DEGENERATION; NEUROLOGIC DISEASE; NEWBORN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; CEREBELLUM NUCLEUS; DEGENERATIVE DISEASE; HISTIOCYTOSIS X; METABOLISM; METHODOLOGY; PATHOLOGY; PRESCHOOL CHILD; TIME;

ADOLESCENT; BASAL GANGLIA; CEREBELLAR NUCLEI; CEREBELLUM; CHILD; CHILD, PRESCHOOL; FEMALE; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; INFANT; INFANT, NEWBORN; MAGNETIC RESONANCE IMAGING; MALE; NEURODEGENERATIVE DISEASES; TIME FACTORS;

EID: 47649086504     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2007.12.042     Document Type: Article

References (32)

1. Arceci R. The histiocytoses: the fall of the Tower of Babel. Eur J Cancer 35 (1999) 747-767
2. Laman J.D., Leenen P.J., Annels N.E., Hogendoorn P.C., and Egeler R.M. Langerhans-cell histiocytosis "insight into DC biology.". Trends Immunol 24 (2003) 190-196
3. Schueller A. Über eigenartige Schädeldefekte im Jugendalter. Fortschr Geb Röntgenstr 23 (1915) 12-19
4. Christian H.A. Defects in membranous bones, exophthalmos and diabetes insipidus; an unusual syndrome of dyspituitarism: a clinical study. Med Clin N Am 3 (1920) 849-871
5. Hand A. Defects of membraneous bones, exophthalmus and polyuria in childhood: is it dyspituitarism?. Am J Med Science 162 (1921) 509-515
6. Grois N., Tsunematsu Y., Barkovich A.J., and Favara B.E. Central nervous system disease in Langerhans cell histiocytosis. Br J Cancer Suppl 23 (1994) S24-S28
7. Barthez M.A., Araujo E., and Donadieu J. Langerhans cell histiocytosis and the central nervous system in childhood: evolution and prognostic factors. Results of a collaborative study. J Child Neurol 15 (2000) 150-156
8. Prayer D., Grois N., Prosch H., Gadner H., and Barkovich A.J. Magnetic resonance imaging presentation of (intra) cranial disease associated with Langerhans cell histiocytosis. Am J Neuroradiol 25 (2004) 880-891
9. Martin-Duverneuil N., Idbaih A., Hoang-Xuan K., Donadieu J., Genereau T., Guillevin R., et al. MRI features of neurodegenerative Langerhans cell histiocytosis. Eur Radiol 16 (2006) 2074-2082
10. Gadner H., Heitger A., Grois N., Gatterer-Menz I., and Ladisch S. Langerhans cell histiocytosis in childhood-results of the DAL-HX 83 study. Klin Padiatr 199 (1987) 173-182
11. Thomas C., Donadieu J., Emile J.F., and Brousse N. Langerhans cell histiocytosis. (1996). Arch Pediatr 3 (1996) 63-69
12. Nanduri V.R., Bareille P., Pritchard J., and Stanhope R. Growth and endocrine disorders in multisystem Langerhans' cell histiocytosis. Clin Endocrinol (Oxf) 53 (2000) 509-515
13. Grois N., Favara B.E., Mostbeck G.H., and Prayer D. Central nervous system disease in Langerhans cell histiocytosis. Hematol Oncol Clin North Am 12 (1998) 287-305
14. Saatci I., Baskan O., Haliloglu M., and Aydingoz U. Cerebellar and basal ganglion involvement in Langerhans cell histiocytosis. Neuroradiology 41 (1999) 443-446
15. Polizzi A., Coghill S., McShane M.A., and Squier W. Acute ataxia complicating Langerhans cell histiocytosis. Arch Dis Child 86 (2002) 130-131
16. Idbaih A., Donadieu J., Barthez M.A., Geissmann F., Bertrand Y., Hermine O., et al. Retinoic acid therapy in degenerative-like neuro-Langerhans cell histiocytosis: a prospective pilot study. Pediatr Blood Cancer 43 (2004) 55-58
17. Haupt R., Nanduri V., Calevo M.G., Bernstrand C., Braier J.L., Broadbent V., et al. Permanent consequences in Langerhans cell histiocytosis patients: a pilot study from the Histiocyte Society-Late Effects Study Group. Pediatr Blood Cancer 42 (2004) 438-444
18. Laurencikas E, Stalemark H, Fadeel B, Prayer D, Grois N, Henter JI. Incidence of abnormal magnetic resonance imaging findings of the central nervous system in children with Langerhans Cell Histiocytosis. Presented at the Histiocyte Society 21st Annual Meeting. 2006. [Abstract].
19. Mittheisz E., Seidl R., Prayer D., Waldenmair M., Neophytou B., Pötschger U., et al. Central nervous system-related permanent consequences in patients with Langerhans cell histiocytosis. 1: Pediatr Blood Cancer 48 (2007) 50-56
20. Gadner H., Heitger A., Grois N., Gatterer-Menz I., and Ladisch S. Treatment strategy for disseminated Langerhans Cell Histiocytosis. Med Pediatr Oncol 23 (1994) 72-80
21. Gadner H., Grois N., Aricò M., Broadbent V., Ceci A., Jakobson A., et al. A randomized trial of treatment for multisystem Langerhans Cell Histiocytosis. J Pediatr 138 (2001) 728-734
22. Gadner H., Grois N., Minkov M., and Histiocyte Society. LCH-II Treatment protocol of the second international study for Langerhans cell histiocytosis (1996) Reference Type: Protocol
23. Gadner H., Grois N., Minkov M., Pötschger U., Thiem E., Histiocyte Society, and LCH III Study Committee. Treatment protocol of the third international study for Langerhans cell histiocytosis (2001) Reference Type: Protocol
24. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis and the expanded disability status scale (EDSS). Neurology 33 (1983) 1444-1452
25. Trouillas P., Takayanagi T., Hallett M., Currier R.D., Subramony S.H., Wessel K., et al. International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology. J Neurol Sci 145 (1997) 205-211
26. Grois N., Potschger U., Prosch H., Minkov M., Arico M., Braier J., et al. Risk factors for diabetes insipidus in Langerhans cell histiocytosis. Pediatr Blood Cancer 46 (2006) 228-233
27. Grois N., Prayer D., Prosch H., Minkov M., Potschger U., and Gadner H. Course and clinical impact of magnetic resonance imaging findings in diabetes insipidus associated with Langerhans cell histiocytosis. Pediatr Blood Cancer 43 (2004) 59-65
28. Donadieu J., Rolon M.A., Thomas C., Brugieres L., Plantaz D., Emile J.F., et al. Endocrine involvement in pediatric-onset Langerhans' cell histiocytosis: a population-based study. J Pediatr 144 (2004) 344-350
29. Prosch H., Grois N., Wnorowski M., Steiner M., and Prayer D. Long-term MR imaging course of neurodegenerative Langerhans cell histiocytosis. AJNR Am J Neuroradiol 28 (2007) 1022-1028
30. Grois N., Prayer D., Prosch H., Lassman H., and CNS-LCH-co-operative group. Neuropathology of CNS disease in Langerhans cell histiocytosis. Brain 128 Pt 4 (2005) 829-838
31. Bradley W.G. Recent views on amyotrophic lateral sclerosis with emphasis on electrophysiological studies. Muscle Nerve 10 (1987) 490-502
32. Bjartmar C., Wujek J.R., and Trapp B.D. Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease. J Neurol Sci 206 (2003) 165-171